Clinical trial
Chemoradiotherapy of NSCLC Stage IIIB
NCT00198432 · Intergroupe Francophone de Cancerologie Thoracique, Other · Completed
Key facts
| NCT number | NCT00198432 |
|---|---|
| Title | Chemoradiotherapy of NSCLC Stage IIIB |
| Official title | Randomized Phase II Study Evaluating an Induction Chemotherapy Followed by a Concomitant Chemoradiotherapy and a Concomitant Chemoradiotherapy Followed by a Consolidation Chemotherapy Among Patients With NSCLC Stage III Not Resectable |
| Lead sponsor | Intergroupe Francophone de Cancerologie Thoracique, Other |
| Collaborators | Bristol-Myers Squibb Industry Pierre Fabre Laboratories Ligue contre le cancer, France |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | NSCLC Stage IIIB, Concomitant Radiochemotherapy |
| Intervention type | Drug |
| Interventions | Paclitaxel, vinorelbine, cisplatin |
| Enrollment | 130 |
| Start date | Mar 1, 2002 |
| Completion | Dec 1, 2006 |
| First posted | Sep 20, 2005 |
| Last update posted | Mar 10, 2016 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: